Healthcare
BioNTech Rolls Out a $1 Billion Buyback While Racing Toward Its First Cancer Approval
BioNTech is simultaneously tightening its belt and opening its wallet, a dual move that signals both caution and ambition as...
German Workplace Safety Reform Allows Online Training, Raises Mandatory Safety Officer Threshold to 50 Employees
Every year, workplace accidents and occupational illnesses in Germany drain roughly 85 billion euros from production output and rob the...
Retirement at 70? German Pension Reform Plan Deepens Coalition Rift Over Early-Exit Options
Fresh proposals from Berlin’s Alterssicherungskommission — chaired by Prof. Dr. Constanze Janda and Dr. Frank-Jürgen Weise — have laid out...
Knowledge Exodus and Tech Failures Threaten Germany’s Workforce as Priorities Shift
As the Baby Boomer generation heads into retirement, a massive knowledge drain looms over Germany’s economy. A joint report from...
Trust in AI Collapses Ahead of EU Compliance Deadline – Hybrid Strategies Reveal a Way Forward
Optimism about artificial intelligence in German workplaces has taken a sharp nosedive. An Akkodis survey shows that just 48 percent...
Half of German Workers Eye Early Retirement as Demographic Shift Intensifies Labor Crunch
The DAK-Gesundheitsreport 2026 delivers a sobering snapshot: 44 percent of all employees in Germany plan to leave the workforce before...
From Wrestler’s Neck to Lower Back: Why Herniated Disc Care Needs Faster Diagnosis and Better Funding
A Swiss wrestler’s delayed diagnosis has thrown a spotlight on the challenges facing people with herniated discs — just as...
Bayer Juggles a $2.45 Billion Biotech Bet and a Washington Trade Probe
Bayer’s stock crept back above a closely watched technical threshold on Friday, but the real drama for the German healthcare...
Germany Overhauls Welfare for Jobseekers: Sanctions Tighten, But Only 0.27% Are Labeled ‘Total Refusers’
When Germany’s federal government approved a sweeping reform of its basic income support system in March 2026, the debate was...
Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low
Investors are being presented with two sharply conflicting narratives on Kuros Biosciences. The Swiss biotech firm reported a blistering 72%...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
